MedTrace Logo

A Study Evaluating Blended Belotero for the Treatment of Etched-in Fine Facial Lines

NCT02626598 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2015-12-10

No results posted yet for this study

Summary

This is a single center study for adult females or males ages 25 to 75 years who are seeking treatment for etched-in fine lines of the cutaneous lip, and/or radial cheek area, and/or nasolabial folds, and/or melolabial folds, and/or forehead. The purpose of this study is to evaluate blended Belotero for the treatment of etched-in fine facial lines and to monitor for adverse events.

Conditions

  • Rhytidosis Facialis

Interventions

DEVICE

Blended Belotero

Belotero blended with 0.1 cc of 1% lidocaine with epinephrine per 1.0 cc Belotero will be injected to etched in fine facial lines

Sponsors & Collaborators

  • Merz Aesthetics Inc.

    collaborator INDUSTRY

  • Skin Care and Laser Physicians of Beverly Hills

    lead OTHER

Principal Investigators

  • Derek H Jones, MD · Skin Care and Laser Physicians of Beverly Hills

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02626598 on ClinicalTrials.gov